Announcement of subsequent default of payment by the Company under Para A of sub paragraph 6 of schedule III of SEBI (LODR) Regulations, 2015
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs And Organics has disclosed a subsequent default of payment as required under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. This indicates the company has failed to meet a payment obligation on time, likely related to interest or principal on its borrowings. The disclosure is a regulatory requirement triggered when a listed company defaults on debt servicing. Specific details such as the lender name, amount, and duration of default would be available in the full filing. Such disclosures are typically viewed negatively by investors as they signal liquidity or financial stress at the company.
This is a negative development for shareholders, indicating potential financial difficulty or cash flow issues at the company. It may lead to credit rating downgrades, higher borrowing costs going forward, and could weigh on the stock price due to heightened default risk perception.